Abbott Laboratories ( ABT) - Stock Earnings
ABT Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
April 15, 2025 BeforeMarket | - / - | 10.0 billion | - / 10.4 billion | 10.7 billion |
ABT Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q3 | 1.6 billion USD | 10.6 billion USD |
2024Q2 | 1.3 billion USD | 10.4 billion USD |
2024Q1 | 1.2 billion USD | 10.0 billion USD |
2023Q4 | 1.6 billion USD | 10.2 billion USD |
2023Q3 | 1.4 billion USD | 10.1 billion USD |
ABT Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 5.7 billion USD | 40.1 billion USD |
2022 | 6.9 billion USD | 43.7 billion USD |
2021 | 7.1 billion USD | 43.1 billion USD |
2020 | 4.5 billion USD | 34.6 billion USD |
2019 | 3.7 billion USD | 31.9 billion USD |
ABT
List: Contenders
Price: $131.79
Forward Dividend Yield: 1.79%
Payout Ratio: 69.40%
Dividend Per Share: 2.36 USD
Earnings Per Share: 7.68 USD
P/E Ratio: 16.81
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 5.1 million
Ebitda: 1.7 billionMarket Capitalization: 223.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: 10.93%
DGR5: 12.50%
DGR10: 12.94%
DGR20: 19.33%